The most important discovery was that curcumin inhibited the translocation of high mobility group protein B1 (HMGB1)-NF-κB, thus preventing NASH progression and hepatic injury [52]. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.